These recalled products, packaged in a syringe, vial or eye dropper, were distributed across U.S. healthcare facilities from April 17 to Aug. 10.
The drugmaker issued the recall as a precautionary measure after the FDA identified issues during an inspection of the facility.
Bella Pharmaceuticals is informing customers of the recall and arranging for the return of all affected products.
More articles on supply chain:
Walmart follows Amazon, applies for aerial warehouse patent
7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.